1. Home
  2. BWXT vs TECH Comparison

BWXT vs TECH Comparison

Compare BWXT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWXT
  • TECH
  • Stock Information
  • Founded
  • BWXT 1867
  • TECH 1976
  • Country
  • BWXT United States
  • TECH United States
  • Employees
  • BWXT N/A
  • TECH N/A
  • Industry
  • BWXT
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BWXT
  • TECH Health Care
  • Exchange
  • BWXT Nasdaq
  • TECH Nasdaq
  • Market Cap
  • BWXT 8.6B
  • TECH 7.9B
  • IPO Year
  • BWXT N/A
  • TECH 1989
  • Fundamental
  • Price
  • BWXT $107.19
  • TECH $50.49
  • Analyst Decision
  • BWXT Strong Buy
  • TECH Buy
  • Analyst Count
  • BWXT 10
  • TECH 9
  • Target Price
  • BWXT $126.22
  • TECH $73.88
  • AVG Volume (30 Days)
  • BWXT 837.1K
  • TECH 2.1M
  • Earning Date
  • BWXT 05-05-2025
  • TECH 05-07-2025
  • Dividend Yield
  • BWXT 0.93%
  • TECH 0.64%
  • EPS Growth
  • BWXT 13.77
  • TECH N/A
  • EPS
  • BWXT 3.14
  • TECH 0.83
  • Revenue
  • BWXT $2,781,946,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • BWXT $14.40
  • TECH $8.19
  • Revenue Next Year
  • BWXT $9.80
  • TECH $8.61
  • P/E Ratio
  • BWXT $34.38
  • TECH $59.98
  • Revenue Growth
  • BWXT 9.88
  • TECH 4.72
  • 52 Week Low
  • BWXT $84.21
  • TECH $46.44
  • 52 Week High
  • BWXT $136.31
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • BWXT 54.49
  • TECH 45.07
  • Support Level
  • BWXT $102.42
  • TECH $46.77
  • Resistance Level
  • BWXT $109.58
  • TECH $50.81
  • Average True Range (ATR)
  • BWXT 2.78
  • TECH 2.01
  • MACD
  • BWXT -0.08
  • TECH 0.43
  • Stochastic Oscillator
  • BWXT 54.18
  • TECH 50.52

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: